Sopharma AD Logo

Sopharma AD

Pharmaceutical producer of Rx, OTC, and plant-based medicines for international markets.

SFA | BSOBGN

Overview

Corporate Details

ISIN(s):
BG11SOSOBT18
LEI:
097900BGGW0000048796
Country:
Bulgaria
Address:
ул. Лъчезар Станчев 5, кула А, ет.18, 1756 София

Description

Sopharma AD is a pharmaceutical company founded in 1933 that specializes in the production, distribution, and export of a wide range of medical products. The company's portfolio includes prescription (Rx) and over-the-counter (OTC) medicines, encompassing both branded and generic drugs. A key area of focus is its traditional plant-based products. Sopharma develops treatments for various conditions, including liver disease, pain management, and smoking cessation. Operating from EU-GMP certified facilities, the company also provides contract manufacturing services and has an established presence in over 40 international markets.

Social Media

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-22 16:42
Notification for sale of treasury shares
Polish 127.0 KB
2025-12-22 14:04
Sales revenues for November
Polish 142.1 KB
2025-12-22 09:42
Notification from Donev Investments Holding AD in accordance with Regulation 59…
English 175.4 KB
2025-12-22 09:24
Notification for sale of treasury shares
English 128.8 KB
2025-12-19 12:25
Notification from Donev Investments Holding AD in accordance with Regulation 59…
English 175.7 KB
2025-12-19 09:20
Notification for sale of treasury shares
English 129.1 KB
2025-12-18 09:53
Notification for sale of treasury shares
English 129.2 KB
2025-12-17 09:22
Notification for sale of treasury shares
English 129.2 KB
2025-12-16 09:15
Notification for sale of treasury shares
English 129.1 KB
2025-12-15 10:23
Notification for sale of treasury shares
English 126.7 KB
2025-12-12 13:18
Corrective notification of an initial notification published on 11.12.2025 from…
English 189.3 KB
2025-12-12 13:11
Corrective notification of an initial notification published on 11.12.2025 from…
English 185.3 KB
2025-12-12 13:00
Corrective notification of an initial notification published on 04.12.2025 from…
English 186.9 KB
2025-12-12 12:07
Notification for sale of treasury shares
English 128.1 KB
2025-12-11 15:08
Notification from Ognian Donev in accordance with Regulation 596/2014 for trans…
English 188.6 KB

Automate Your Workflow. Get a real-time feed of all Sopharma AD filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Sopharma AD

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for Sopharma AD via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Access Bio, Inc. Logo
Develops and manufactures in vitro diagnostic solutions for infectious diseases.
United States of America
950130
ACHIEVE LIFE SCIENCES, INC. Logo
A late-stage pharmaceutical company developing a treatment for nicotine dependence.
United States of America
ACHV
AC Immune SA Logo
Biopharmaceutical firm developing precision medicine for neurodegenerative diseases.
United States of America
ACIU
Aclaris Therapeutics, Inc. Logo
Clinical-stage biopharmaceutical company developing drugs for immuno-inflammatory diseases.
United States of America
ACRS
Acrivon Therapeutics, Inc. Logo
Clinical-stage biopharma using proteomics to develop precision oncology therapies.
United States of America
ACRV
Acticor Biotech Logo
Develops treatments for thrombotic diseases, focusing on acute ischemic stroke.
France
ALACT
Actinium Pharmaceuticals, Inc. Logo
Clinical-stage company developing targeted radiotherapies for difficult-to-treat cancers.
United States of America
ATNM
ACTUATE THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing therapies for cancers with high unmet needs.
United States of America
ACTU
AcuCort AB Logo
Develops user-friendly drug formulations for severe and acute allergic reactions.
Sweden
ACUC
Acumen Pharmaceuticals, Inc. Logo
Clinical-stage biopharma developing targeted therapies for Alzheimer's disease.
United States of America
ABOS

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.